about
Global health leadership training in resource-limited settings: a collaborative approach by academic institutions and local health care programs in UgandaNurses' knowledge in ethics and their perceptions regarding continuing ethics education: a cross-sectional survey among nurses at three referral hospitals in Uganda.A need to accelerate health research productivity in an African University: the case of Makerere University College of Health SciencesHigh T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.Parasite-based malaria diagnosis: are health systems in Uganda equipped enough to implement the policy?Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda.Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.Mentorship needs at academic institutions in resource-limited settings: a survey at Makerere University College of Health Sciences.Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda.Sub-optimal vitamin B-12 levels among ART-naïve HIV-positive individuals in an urban cohort in Uganda.Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda.Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohortIntra-facility linkage of HIV-positive mothers and HIV-exposed babies into HIV chronic care: rural and urban experience in a resource limited settingClinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in UgandaPredictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda.CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.Acute Spontaneous Coronary Artery Thrombosis as Initial Presentation of HIV Infection in a Young Man.Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic TechnologyAtorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohortPrevalence, barriers and factors associated with parental disclosure of their HIV positive status to children: a cross-sectional study in an urban clinic in Kampala, Uganda.Training tomorrow's leaders in global health: impact of the Afya Bora Consortium Fellowship on the careers of its alumniEligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in UgandaPolicy development, implementation and evaluation by the AIDS control program in Uganda: a review of the processes.Interprofessional Fellowship Training for Emerging Global Health Leaders in Africa to Improve HIV Prevention and Care: The Afya Bora Consortium.CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda.Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significanceDoctoral training in Uganda: evaluation of mentoring best practices at Makerere university college of health sciences.High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program.Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda.Aetiology of diarrhoea among persons with HIV and their family members in rural Uganda: a community-based study.Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda.Disclosure of Parental HIV Status to Children: Experiences of Adults Receiving Antiretroviral Treatment at an Urban Clinic in Kampala, Uganda.Elevated inflammatory cytokines in aqueous cytokine profile in HIV-1 infected patients with cataracts in Uganda.Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells.Reaching the First 90 in Uganda: Predictors of Success in Contacting and Testing the Named Sexual Partners of HIV+ Index Clients in Kiboga District.
P50
Q28551019-01031E49-CFFE-43C6-8B82-F3FA85B598A7Q30659206-F27CCCD2-8D9A-4230-83AD-514B6B879090Q30846690-B1F52644-2DAD-43B6-91DA-C347652EAB75Q30999041-CA628156-BD3D-47E9-AB4E-90E406185AD2Q31055855-1856C96F-E742-473C-9546-1BBB5CD02A3EQ33263209-3A39DBAB-6DAE-45CB-B960-7E7DE2EB61E1Q33707759-B0525158-C746-4989-92FA-97ECEED4C2C9Q33975618-CD4E54D0-C620-47EE-88F5-2D559CD6D7FDQ34036526-9D0FF4DD-C27F-48BF-BB60-51ABD3EA34DEQ34329071-46A86041-724E-4F14-A6AC-4AD90EFB6641Q34347685-3FA20A84-9A50-4D4A-AD60-531F75DB78C8Q34359439-151840F7-42B9-4744-AD64-4F61402130B6Q34764823-DC163E45-79D1-4D8A-9F7C-F688677D866FQ34779237-A2439D12-D25C-4208-97D5-48A7B59513D2Q34784808-80608779-9C92-4C33-A8B6-14E2F1FD2F22Q34989654-E2CE9901-CF4F-4472-9785-6CD7E00C6CBAQ35094781-675C0C20-5AB2-4356-B901-829FC8029A4AQ35107571-4DA3D748-BB86-4776-8C60-A5BB6E83DE2EQ35119369-68B1BDE6-F0CC-4EB1-BDFB-1DE9F4B2EE20Q35187972-28246CAB-3B49-4275-95F2-7B814202960CQ35722812-250AEC73-6288-461E-B453-409240AAFD47Q35929446-24DF9A13-E370-4B4B-A67A-DE3594A1989EQ35956923-1A8DFBF2-37B1-4BB9-B6F5-5D1876FFFC99Q36073278-269FCAE6-6772-4C20-83AB-826C68280A92Q36137079-27320111-B8E5-4B51-BE5A-4FF333724D03Q36500741-CC9A658D-E17F-4C2B-AFCD-BB22873E370EQ36686801-5256DBE4-1274-46F3-A4F3-D2A1D3A448E7Q36806473-F20306F3-30D1-4F2D-885B-FF8ABE1C3395Q37002936-48ABE306-35E2-4476-BB99-E6B75C5DC5D5Q37021073-7059989F-DB3B-471E-97F9-0CD760EF1921Q37501175-1F88B3AB-1832-4B44-8D66-D6C0FCCD3954Q37558647-8D925557-F551-438F-A0F5-9DCA92C1D8CCQ37660215-00DDA2B4-F902-4C92-86A3-7B5BB021FB45Q38871206-B43FDF38-865A-4591-A90B-3ACAA23001D4Q38873882-153A9F42-868C-4D93-8EA6-88B701A1DA6EQ38880212-113EED39-1A21-4AC2-8787-A319E757DE3AQ45820077-DDE84010-3C01-446F-A0B6-256C85B19798Q48205565-0341DDDD-D154-47F4-92F3-9BFDBF5B5420Q52653716-8C93DE3A-959F-4618-896F-31DC6FF97BC3Q53682740-3D65CF81-8CFE-4169-A77A-80ECBCEF894D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Damalie Nakanjako
@ast
Damalie Nakanjako
@en
Damalie Nakanjako
@es
Damalie Nakanjako
@nl
Damalie Nakanjako
@sl
type
label
Damalie Nakanjako
@ast
Damalie Nakanjako
@en
Damalie Nakanjako
@es
Damalie Nakanjako
@nl
Damalie Nakanjako
@sl
prefLabel
Damalie Nakanjako
@ast
Damalie Nakanjako
@en
Damalie Nakanjako
@es
Damalie Nakanjako
@nl
Damalie Nakanjako
@sl
P106
P31
P496
0000-0002-0935-2112